Authors
Loading...
Evaluation of preoperative CA19-9 and NLR predicts early recurrence in patients with pancreatic ductal adenocarcinoma, implying potential for improved outcomes.
Ye et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: